使CRISPR,使

Yuqi Wang1, Mangze Hu2, Yilong Zou1

  • 1Westlake Four-Dimensional Dynamic Metabolomics (Meta4D) Laboratory, Westlake Laboratory of Life Sciences and Biomedicine, Hangzhou, Zhejiang 310024, China; School of Life Sciences, Westlake University, Hangzhou, Zhejiang 310024, China.

STAR protocols
|September 18, 2025
PubMed
概括

这项研究详细介绍了体内CRISPR查协议,以识别驱动活体卵巢癌转移的基因. 这种方法克服了基于实验室模型发现关键转移基因的局限性.